RH (RH) stock analysis
Close on Nov 11, 2026Market cap $2.57BP/E 24.2Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed13 of 30 checks passed
RH passes 13 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 2/6
- Past performance
- 2/6
- Financial health
- 5/6
- Dividend
- 0/6
What stands out
Margin of safety over 20%
The price is 23.2% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $135.90 is below our fair value estimate of $176.90.
No debt
RH has no borrowings on its latest balance sheet.
Earnings growth accelerating
Net income grew 4.4% over the last twelve months, against a 5-year average of -14.4% a year.
What to watch
Earnings shrank over 5 years
Net income shrank 14.4% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew -1.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -31.8% a year over the last three fiscal years.
Elevated bankruptcy risk
The Altman Z-score is 1.14; above 3 is the safe zone and below 1.8 the distress zone.
Valuation4/6
P/E below its 5-year median
RH's P/E of 24.2 is below its own 5-year median of 27.9.
P/E above the industry
RH's P/E of 24.2 is above the Consumer discretionary median of 19.6.
EV/EBITDA below its 5-year median
RH's EV/EBITDA of 4.9 is below its 5-year median of 6.7.
P/B above the industry
RH's price-to-book of 21.38 is above the Consumer discretionary median of 4.85.
Trading below fair value
The share price of $135.90 is below our fair value estimate of $176.90.
Margin of safety over 20%
The price is 23.2% below fair value, more than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew -1.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -31.8% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 4.4% over the last twelve months, against a 5-year average of -14.4% a year.
Growing faster than the industry
Revenue grew 3.3% over the last twelve months; the Consumer discretionary median is 2.2%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 44.3% over the last twelve months, against 44.6% a year earlier.
Past performance2/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
RH's return on equity of 281% is above the Consumer discretionary median of 15.7%.
Earnings shrank over 5 years
Net income shrank 14.4% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 3.2% over the last twelve months, against a 5-year average of 8.6%.
Net margin above the industry
RH's net margin of 3.2% is above the Consumer discretionary median of 3.1%.
Financial health5/6
No debt
RH has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term assets cover short-term debts
Current assets are 1.12 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 1.14; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
RH has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$176.90
The share price is 23% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 23.8× | 27.9× | 19.6× | $133.72 | 53% |
| EV/EBITDA | 8.3× | 6.7× | 9.8× | $226.25 | 47% |
| Earnings powerleft out, too far from the others | 14.9% cost of equity | – | – | $32.40 | – |
| Fair value | $176.90 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 27.9
- Consumer discretionary median 19.6
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $107.30M
- Value traded per 1% price move
- $40.49M
Downside
High risk
- Typical loss in a bad month
- 34.4%
- Volatility (annualized)
- 62%
- Sharpe ratio, 1 year
- -0.29
- Beta to the S&P 500 (5Y)
- 2.21
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +8.1% | -1.4% | +3.8% | +5.0% | |
| Gross profit | +7.1% | -5.8% | +2.7% | +7.3% | |
| Operating income | +20.1% | -18.8% | -3.7% | +7.6% | |
| Net income | +72.3% | -38.2% | -14.4% | +3.2% | |
| EPS, diluted | +74.3% | -31.8% | -8.7% | +11.3% | |
| Free cash flow | – | +3.1% | -8.3% | +42.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 0.6% | 116.7% | -242.3% | |
| Return on assets | 0.3% | 10.2% | 2.7% | |
| Current ratio | 2.74 | 0.87 | 1.19 | |
| Debt to equity | – | 0.08 | – | |
| Net debt to EBITDA | – | -0.11× | – | |
| Interest coverage | 1.2× | 6.7× | 1.7× | |
| Capex to revenue | 8.0% | 3.9% | 5.8% | |
| Diluted shares | 41M | 27M | 20M |
Where the cash went
Fiscal 2021 to 2025, five years combined
RH generated $1.74B from operations and spent $3.32B on capital expenditure, dividends and share buybacks. 32% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 3.6% | 0.73× | -91.18× | -242.3% |
| FY2024 | 2.3% | 0.73× | -18.87× | -31.4% |
| FY2023 | 4.2% | 0.64× | 19.40× | 52.4% |
| FY2022 | 14.7% | 0.66× | 5.55× | 54.1% |
| FY2021 | 18.3% | 0.89× | 5.22× | 85.1% |
| FY2020 | 9.5% | 1.07× | 11.48× | 116.7% |
| FY2019 | 8.3% | 1.09× | -242.96× | -2199.5% |
| FY2018 | 5.4% | 1.21× | -88.72× | -579.5% |
| FY2017 | -0.1% | 1.24× | 4.29× | -0.6% |
| FY2016 | 0.3% | 1.00× | 2.35× | 0.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$124.79M
- Cash generatingOperating cash flow above zero$452.24M
- Return on assets improvedROA up on the prior year1.7% → 2.7%
- Earnings backed by cashOperating cash flow above net income$452.24M vs $124.79M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.43 → 1.19
- No dilutionShare count did not rise20M → 20M
- Gross margin improvedGross margin up on the prior year44.48% → 44.07%
- More efficientAsset turnover rose0.77 → 0.76
See a number that looks wrong?